Total Body Irradiation: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG)

Jeffrey Y C Wong; Andrea Riccardo Filippi; Bouthaina Shbib Dabaja; Joachim Yahalom; Lena Specht

doi:10.1016/j.ijrobp.2018.04.071

Total Body Irradiation: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG)

Int J Radiat Oncol Biol Phys. 2018 Jul 1;101(3):521-529. doi: 10.1016/j.ijrobp.2018.04.071. Epub 2018 May 2.

Authors

Jeffrey Y C Wong¹, Andrea Riccardo Filippi², Bouthaina Shbib Dabaja³, Joachim Yahalom⁴, Lena Specht⁵

Affiliations

¹ Department of Radiation Oncology, City of Hope Cancer Center, Duarte, California.
² Department of Oncology, University of Torino, Torino, Italy.
³ Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
⁴ Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
⁵ Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. Electronic address: lena.specht@regionh.dk.

PMID: 29893272
DOI: 10.1016/j.ijrobp.2018.04.071

Abstract

Total body irradiation (TBI) remains an effective myeloablative treatment in regimens used for preparation and conditioning before allogeneic stem cell transplantation for leukemia. The regimens used vary across institutions in terms of dose, dose rate, fractionation, and technique. The objective of this document is to provide comprehensive guidelines for the current practice of delivering total body irradiation.

Publication types

Review

MeSH terms

Humans
Internationality*
Lymphoma / radiotherapy*
Practice Guidelines as Topic*
Societies, Medical*
Whole-Body Irradiation / instrumentation
Whole-Body Irradiation / methods*